Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Trinity Biotech plc Company Profile (NASDAQ:TRIB)

Consensus Ratings for Trinity Biotech plc (NASDAQ:TRIB) (?)
Ratings Breakdown: 1 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $27.30 (17.67% upside)

Analysts' Ratings History for Trinity Biotech plc (NASDAQ:TRIB)
Show:
DateFirmActionRatingPrice TargetDetailsShare
5/14/2014ZacksUpgradeUnderperform -> Neutral$24.60ViewTweet This Rating  Share This Rating on StockTwits
4/30/2014Roth CapitalUpgradeNeutral -> Buy$28.00 -> $30.00ViewTweet This Rating  Share This Rating on StockTwits
3/5/2014Roth CapitalBoost Price Target$22.00 -> $28.00ViewTweet This Rating  Share This Rating on StockTwits
2/18/2014ZacksDowngradeNeutral -> Underperform$25.50ViewTweet This Rating  Share This Rating on StockTwits
11/19/2013SidotiInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
10/30/2013ZacksDowngradeOutperform -> Neutral$26.60ViewTweet This Rating  Share This Rating on StockTwits
10/1/2013ZacksUpgradeNeutral -> Outperform$23.10ViewTweet This Rating  Share This Rating on StockTwits
3/7/2013Roth CapitalBoost Price Target$15.50 -> $17.50ViewTweet This Rating  Share This Rating on StockTwits
3/5/2013Craig HallumInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
1/22/2013Roth CapitalDowngradeBuy -> Neutral$15.50ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/25/2012 forward)